假基因CSPG4P12通过减弱表皮细胞-介质细胞过渡来抑制结直肠癌的进展
Qinqin Song1,2, Hongxue Xu3, Hongjiao Wu3
1Department of Oncology, Hebei Medical University, Shijiazhuang, China.
概括
伪基因CSPG4P12在结肠直肠癌中是下调的. 它的过度表达抑制了瘤生长,入侵和迁移,这表明CSPG4P12是结直肠癌的潜在治疗标.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 结肠直肠癌是一种常见的恶性瘤.
- 伪基因可以作为瘤基因或瘤抑制剂发挥作用.
- 目前尚不清楚CSPG4P12在结直肠癌中的作用.
研究的目的:
- 为了研究伪基CSPG4P12在结直肠癌中的功能.
- 探索CSPG4P12作用的潜在机制.
- 评估CSPG4P12作为一个潜在的治疗目标.
主要方法:
- 使用GEPIA对结直肠癌组织中CSPG4P12表达的分析与正常组织的分析2.2.
- 在体外测试:细胞活力,殖民地形成,Transwell迁移和伤口愈合.
- 对表皮细胞-介质细胞过渡 (EMT) 相关蛋白质的西部斑点分析.
主要成果:
- 与相邻的正常组织相比,在结直肠癌组织中,CSPG4P12的表达显著较低.
- 过度表达CSPG4P12可以抑制结直肠癌细胞的扩散,入侵和迁移.
- 在CSPG4P12中,过度表达对E-cadherin进行上调,对维门丁,N-cadherin和MMP9进行下调.
结论:
- 在结直肠癌中,CSPG4P12作为瘤抑制剂起作用.
- 通过抑制EMT,CSPG4P12可以抑制结直肠癌的进展.
- CSPG4P12代表着对结直肠癌治疗的有前途的新型治疗标.
相关概念视频
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
Pleiotropy
40.4K
Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
40.4K
Cancer-Critical Genes II: Tumor Suppressor Genes
7.4K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.4K
Induced Pluripotent Stem Cells
4.0K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.0K
Inhibition of Cdk Activity
4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K


